ArticleFrontiers in oncology2022

Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients.

Chao Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.